Biotech and nanomedicine innovations

Combining lattice cryptography with biochemical signaling for secure molecular communication systems

lattice cryptography biochemical signaling molecular communication post-quantum encryption synthetic biology

Targeting cellular senescence through interdisciplinary approaches combining CRISPR and nanomedicine

cellular senescence CRISPR nanomedicine aging gene therapy

In picocubic reaction chambers for single-molecule enzymatic activity analysis

picocubic chambers single-molecule analysis enzyme kinetics nanobiotechnology microfluidics

Reengineering Renaissance designs for ultra-efficient microfluidic lab-on-a-chip devices

Renaissance engineering microfluidics lab-on-a-chip historical designs diagnostic devices

Accelerating antiviral drug discovery using reaction prediction transformers for pandemic preparedness

reaction prediction transformers antiviral drugs pandemic response AI drug discovery computational chemistry

Accelerating drug discovery using computational retrosynthesis with transformer-based models

computational retrosynthesis drug discovery transformer models synthetic pathways pharmaceuticals

Using gate-all-around nanosheet transistors in femtoliter volumes

nanosheet transistors femtoliter tech bioelectronics cellular interfaces nanofabrication

Uniting explainability through disentanglement with unconventional methodologies in AI-driven drug discovery

explainable AI drug discovery disentanglement methods unconventional methodologies transparent machine learning

For enzyme turnover numbers: high-throughput single-molecule fluorescence tracking

enzyme kinetics single-molecule tracking fluorescence microscopy turnover number high-throughput screening

Through accidental discovery pathways in antibiotic-resistant bacteria treatment

accidental discovery antibiotic resistance microbiology novel therapies pathogen treatment

Using reaction prediction transformers to accelerate drug discovery pipelines

reaction prediction transformers drug discovery AI pharmaceuticals

Optimizing drug discovery using computational retrosynthesis for rare diseases

computational retrosynthesis drug discovery rare diseases AI orphan drugs